Objective. To determine if intra-articular (IA) injection of corticosteroids is effective in reducing the need for radiofrequency ablation (RFA) in those with dual comparative medial branch block (MBB)-confirmed lumbar z-joint pain. Design. This was a randomized, double blind, placebo-controlled study. Setting. Two academic medical centers. Subjects. Fifty-six consecutive subjects who had 80% pain relief during an initial screening MBB were recruited. Methods. Patients received a second confirmatory MBB and concurrent IA injection of either corticosteroid or saline per randomization. Twenty-nine of 56 received intra-articular corticosteroid (triamcinolone 20 mg), of whom 24 also had a positive confirmatory MBB per Spine Interventional Society guidelines, with 80% pain relief from both MBBs. Twenty-seven of 56 received IA saline into the z-joint during the confirmatory MBB, of whom 22 also had a positive confirmatory MBB. The primary outcome measure was the categorical need for RFA due to insufficient pain relief with intra-articular injection, and the secondary outcome was time to RFA. Results. There was no statistically significant difference in the need for an RFA between the groups (16/24 steroid, 67%, 95% confidence interval [CI] ¼ 47-82%) vs 15/22 saline (68%, 95% CI ¼ 47-84%, P ¼ 1.00). The average time to RFA was also not different, at 6.00 weeks for steroids vs 6.55 weeks for saline (P ¼ 0.82). Conclusions. Intra-articular corticosteroids were not effective in reducing the need for or the time to a radiofrequency ablation of the medial branches in those with dual MBB-confirmed lumbar z-joint pain.
Introduction
Lumbar zygapophyseal joints (z-joints) are the only true synovial joints between spinal levels in humans and are commonly affected by degenerative changes and osteoarthritis, implicating them as a potential cause of low back pain [1] [2] [3] . Using anesthetic blocks as diagnostic criteria, prevalence rates of lumbar z-joint-mediated pain in patients with chronic low back pain have been quoted at 5-37% [3, 4] . Given that corticosteroids are commonly administered for peripheral osteoarthritis, it has been postulated that they are also effective for the treatment of lumbar z-joint-mediated pain.
Medial branch blocks (MBBs) followed by radiofrequency ablation (RFA) are a validated treatment strategy for z-joint-mediated pain [5] . A large prospective clinical audit followed 174 patients after RFA and found that more than 68% had good to excellent pain relief lasting from six to 24 months [6] . What is less certain is the role of intra-articular (IA) corticosteroid injections into the z-joints. A review of the literature revealed multiple trials investigating the role of intra-articular steroid injections for z-joint-mediated low back pain. However, most of these studies had significant flaws, most notably in their patient selection criteria. Numerous studies have demonstrated that history, physical exam, and imaging are of limited utility in the diagnosis of z-joint-mediated pain [3, [7] [8] [9] . Given the heterogeneous populations without rigorously confirmed z-joint-mediated pain, conclusions drawn from these studies are limited [10] . Medial branch blocks are recommended by the Spine Interventional Society (SIS) for the diagnosis of z-jointmediated pain and for determining candidacy for more definitive treatment by RFA [11] . A single medial branch block has been found to have a false-positive rate as high as 38% [12] . For this reason, it is recommended that dual comparative medial branch blocks be used as a method of diagnosing z-joint-mediated pain.
Here, we have conducted a study evaluating the efficacy of IA steroid injections for lumbar z-joint-mediated pain confirmed by dual comparative MBBs. A homogeneous group of patients was used based on positive response to dual comparative medial branch blocks.
Methods
This was a prospective, randomized, double-blind, placebo-controlled study conducted at two academic medical centers on consecutive patients. This study was approved by institutional review boards from both institutions (full information and clinical trial registration number withheld to preserve anonymity). The Spine Intervention Society funded the study.
Patients experiencing chronic low back pain were clinically evaluated by either a board-certified physical medicine and rehabilitation (PM&R) physician or a board-certified orthopedic spine surgeon in an outpatient spine clinic. Based on clinical suspicion of z-joint-mediated low back pain, subjects were selected for a single diagnostic medial branch block procedure if the following criteria were met: 1) pain rating 4/10 on the 0-10 numeric pain rating (NPR) scale, 2) symptom duration of three or more months, and 3) failed conservative therapy (minimum of physical therapy and medications). A combination of magnetic resonance imaging (MRI) or computed tomography findings and clinical examination was used to determine the target sites. MBBs could be performed at single or multiple levels and could be performed unilaterally or bilaterally.
Exclusion criteria included inability to undergo fluoroscopically guided procedures, inability to speak/read English, current pregnancy, and allergies to medications utilized.
In accordance with SIS guidelines [11] , MBBs were performed using fluoroscopy for needle localization and contrast dye to ensure correct needle placement and avoidance of intravascular flow. The target needle placement was at the junction of the superior articular process and the transverse process. Once correct needle placement was confirmed with injection of contrast dye, approximately 0.3 mL of 0.5% bupivacaine was injected. The process was repeated for each target level.
Immediately after the procedure, subjects were assessed clinically using provocation maneuvers based on preoperative screening examination, and they were given a pain diary. A positive block was defined as 80% improvement in low back pain by perceived percentile improvement or by percent improvement on numeric scale within three hours after the procedure. If the initial MBB was positive, then subjects were offered a second MBB with 2% lidocaine, and these subjects who received the second MBB were offered enrollment in the study. The same approach as the first block was used for the second block.
Once enrolled in the study, subjects were randomly assigned to receive either 0.5 mL of triamcinolone 40 mg/ mL (Bristol-Myers Squibb Company, Princeton, NJ, USA) or 0.5 mL of preservative-free normal saline. After performance of the second MBB (while still prone on the treatment table), the triamcinolone or normal saline was administered intra-articularly into the z-joints that were identified during the first MBB. The maximum number of z-joints targeted was 4, and there was no administration of pain medications (intravenous or oral), anxiolytics, or any other form of conscious sedation before or during the procedure. The lumbar z-joint IA injections were performed in accordance with SIS guidelines for IA z-joint needle placement [11] . Fluoroscopic guidance was used for the IA injections, with multiplanar fluoroscopy used to confirm needle placement and a 0.1-0.2-mL contrast dye injection administered under live fluoroscopy.
The subjects and treating physicians were blinded to the treatment conditions. An interventional PM&R spine fellow performed the injection to assist with blinding. The medications were drawn up by the spine fellow away from the attending, and the syringe was concealed with gauze. If needed, the attending physician would insert the needle and confirm position within the joint via injection of contrast dye (Figures 1-7) . Additionally, to maintain blinding after the needle was placed and confirmed by contrast, the attending physician removed their gloves and stepped out of the treatment area. This allowed the attending physician to remain blinded. By combining the second MBB with the IA injection, recruitment was facilitated, and subjects avoided subsequent procedures accompanied by additional radiation exposure and additional procedural and facility costs. Spine Intervention Society guidelines [12] were followed for all injections, including MBB and lumbar z-joint injections.
After the second MBB, as with the first procedure, patients were assessed immediately postinjection for pain relief and were issued a pain diary. A positive block was defined as 80% relief according to percent improvement on the pain numeric rating scale or by perceived improvement. Patients who did not achieve 80% relief were not included in the final analysis (Diagram 1). Additionally, patients were excluded if they experienced longer duration of relief with the second MBB, which was performed with 2% lidocaine, compared with the first MBB, which was performed with 0.5% bupivacaine.
The primary outcome measure was progression toward RFA. This was chosen as an outcome as, in the real-world setting, pain outcome is not always assessed. However, electing to progress to RFA itself represented insufficient pain relief after the intra-articular injection. The secondary outcome was time to RFA. At the second academic medical center, we were able to track the average NPR scores at one year after enrollment and whether the patient achieved a significant decrease in pain (defined as achieving 0-2/10 average pain at the time of assessment). Statistically, demographics of the steroid and control groups were compared via the Student t test or chi-square test. The chi-square test was used to compare the number of patients who progressed to RFA; the t test was used to assess the time to RFA and pain level at one year with relation to having progressed to RFA or not.
Results
There were 56 subjects enrolled in the study. However, 10 patients, five each in the saline and corticosteroid groups, had a second medial branch block that was negative and thus were not included in the final analysis. In total, 46/56 (82.1%) had a positive confirmatory block.
The mean age at enrollment was 60.8 years (Table 1 ). There were 35 female subjects and 21 male subjects. Age and gender distribution were similar between the groups, as was the anatomic level of the z-joints targeted. There were no statistical differences between the two groups.
In the group receiving saline, 15/22 progressed to receive RFA (68%, 95% confidence interval [CI] ¼ 47-84%). In the corticosteroid group, 16/24 progressed to receive RFA (67%, 95% CI ¼ 47-82%). There was no statistically significant difference between the two groups in the need to progress to RFA (P ¼ 1.00) ( Table 2 ). There was also no statistically significant difference in the average time to RFA, which was 6.5 weeks for the saline group and six weeks for the steroid group (P ¼ 0.82) ( Table 3) .
In the 28 patients in whom we assessed NRS pain data at the one-year mark, 7/17 (41%, 95% CI ¼ 21-64%) who progressed to RFA had significantly decreased pain (with a pain score of 0-2/10). In contrast, only 1/11 (9%, 95% CI ¼ 2-37%) of those who did not progress to RFA achieved a pain score of 0-2/10 at one-year follow-up.
Discussion
Here, we performed the first large study to look at the efficacy of IA steroid injections for z-joint-mediated pain utilizing dual controlled MBBs as diagnostic criteria for enrollment. Our results showed that intra-articular corticosteroids were not effective in reducing the need for or prolonging the time to further treatments for z-joint-mediated pain, namely RFA. Should steroids had provided meaningful pain relief over the saline group, we would have anticipated that fewer in the steroid group would have needed to progress to further treatment for their confirmed z-joint pain. In both groups, >60% eventually progressed to RFA within six to seven weeks.
Our strict criteria for z-joint-mediated pain are important, as numerous studies have shown that history, physical examination, and imaging modalities are nonspecific for the diagnosis of z-joint-mediated pain [3, [7] [8] [9] . Even single intra-articular blocks and single medial branch nerve blocks failed to predict response to definitive therapy such as RFA. Birkenmaier and colleagues showed that patients selected by pericapsular block did not do as well with medial branch cryodenervation as those selected by MBBs [13] . Single medial branch blocks have been shown to have a false-positive rate of as high as 38% in predicting response to a second medial branch block [12] .
It is notable that our enrollment population of patients with a positive response to the first medial branch block had a high rate of concordant response to the second medial branch block. In both treatment groups, the rate of positive response to the second medial branch block was >80%. This is in contrast to prior studies, where the rate of second positive blocks has been reported to be as low as 68% [14] , though others have reported rates as high as 79% [15] . This may have partially accounted for the lower response rate from the RFA at one year, where only 41% had a pain score of 0-2/10. Although the 95% confidence intervals overlapped for this outcome measure between these two groups (21-64% vs 2-37%), we suspect that a true difference may have been observed had there been a larger number of patients in the analysis of this subset. Our findings support prior trials that showed no difference between intra-articular steroid or saline injections for z-joint-mediated pain, though these trials had less stringent patient selection criteria. Lilius and colleagues evaluated the effects of intra-articular steroid for z-joint pain diagnosed by physical examination and imaging findings, without diagnostic injections. They found no difference between steroid vs saline in 109 patients randomized to intra-articular steroid, intra-articular saline, or pericapsular steroid injections. However, in addition to the suboptimal patient selection criteria, despite the 1-2-mL capacity of a lumbar z-joint [16] , 8 mL was reported to have been injected into the joints during this study. This calls into question the accuracy of needle placement within the z-joints during this trial [17] . Carette's group, which selected patients based on 50% reduction in pain following one intra-articular block, found that patients displayed no significant pain reduction at one month after receiving methylprednisolone as compared with saline [18] .
Of note, we did find that the average time to pursuing RFA in this study was 6.0 and 6.5 weeks for steroid and saline, respectively. Customarily, our patients would receive RFA within weeks after their MBBs. The relative delay demonstrated in our results may be due to placebo effects of the intra-articular steroid or saline injection. It can also be theorized that there is a therapeutic dilutional effect or direct effect of capsular distention with intraarticular z-joint injections, although the authors are unaware of any literature demonstrating that 0.5 mL of saline injected into the lumbar z-joints has any therapeutic effect beyond placebo. Another possibility is that given logistics, we had uncharacteristically long wait times to proceed to RFA during the time course of this study, although chart review at the second center revealed no evidence of this.
One of the limitations of our study is that we selected patients based on physiologic criteria according to their response to dual controlled MBBs, and not anatomic criteria addressing the etiology of their pain. This may be flawed, as trials have found that new imaging modalities capable of detecting inflammation may be predictive of response to intra-articular steroid injections to the z-joint. Dolan, Pneumaticos, and Ackerman found that positive SPECT images can predict beneficial response to intra-articular steroid injections at one month and three months [19] [20] [21] .
Another limitation was that pain scores before proceeding to RFA were not documented. Although it can reasonably be assumed that progression to RFA represented insufficient pain relief after the intra-articular injection, quantifiable pain scores such as the visual analog scale may have added to this measure. However, it is possible that the group of patients enrolled would not respond to any treatments. This flaw was noted after enrollment of the initial 28 subjects at the first center [22] . Therefore, to account for this on the subsequent 28 subjects at the second center, we assessed subject pain scores at one year via telephone follow-up with an independent investigator. We then analyzed the rates of patients who reported a 0-2/10 pain scale score during that time frame. This score was chosen to represent those with minimal to no pain. Although not the focus of the study, these rates compared those receiving an RFA with those not undergoing RFA (regardless of randomization). This found that 7/17 (41%) of those who had an RFA had 0-2/10 pain at one year, whereas only 1/11 (9%) of those who did not undergo an RFA had the same low pain score. This demonstrates that the study population can be successfully treated with other treatments such as RFA for a prolonged duration, and therefore justifies the use of RFA as the primary outcome. It also helps to show that without treatment, the natural history for this group with nonspecific chronic low back pain is not favorable.
Overall, given our strict diagnostic criteria, our study can conclude that intra-articular corticosteroids were not effective compared with saline in reducing the need for or prolonging the time to needing to pursue further treatments for z-joint-mediated pain. Future studies need to explore if these injections may benefit a subset of these patients, perhaps those with an inflammatory etiology of pain, as demonstrated by increased peri-z-joint ShortTau Inversion-Recovery signal or postcontrast enhancement on MRI.
